Advertisement

Topics

Proximagen Neuroscience plc Company Profile

22:20 EST 13th December 2018 | BioPortfolio

Proximagen Neuroscience plc is a publicly traded neuroscience research company focused on drug development for neurodegenerative disorders, including Parkinson's disease and Alzheimer's disease.

Proximagen is building a compound pipeline to address the significant unmet medical needs of patients with neurodegenerative disease through its own discovery programme for novel, low risk therapeutic candidates, and through the identification and licensing of existing drugs for new indications.

Location

Hodgkin Building
Guy's Campus King's College London
London
London
SE1 1UL
United States of America

Contact

Phone: +44(0)207.848.6938
Fax: +44(0)207.848.6034
Email: info@proximagen.com


News Articles [427 Associated News Articles listed on BioPortfolio]

Tim Sparey, Head of Business Development talks about Proximagen’s partnering strategy.

In this episode of PharmaTelevision News Review, Fintan Walton talks to Tim Sparey, Head of Business Development at Proximagen

Society for Neuroscience confers Rodolfo Llinás the Ralph W. Gerard Prize in Neuroscience

(Society for Neuroscience) Rodolfo Llinás, MD, PhD, Thomas and Suzanne Murphy Professor of Neuroscience and chairman emeritus of physiology and neuroscience at the New York University School of Medic...

Society for Neuroscience honors scientists dedicated to advancing women in the field

(Society for Neuroscience) The Society for Neuroscience (SfN) will honor individuals who have made significant contributions to the advancement of women in neuroscience during Neuroscience 2018, SfN's...

Award for Education in Neuroscience presented to Erik Herzog and Gönül Peker

(Society for Neuroscience) The Society for Neuroscience (SfN) will award Erik Herzog, PhD, professor of biology at Washington University and director of the St. Louis Neuroscience Pipeline Program, an...

Neuroscience 2018 media registration now open

(Society for Neuroscience) More than 30,000 neuroscience researchers, clinicians, and advocates from around the world will gather Nov. 3-7 in San Diego to share the latest developments in brain resear...

Society for Neuroscience awards Lindsley Prize to Marley Kass

(Society for Neuroscience) The Society for Neuroscience (SfN) will award the Donald B. Lindsley Prize in Behavioral Neuroscience to Marley Kass, PhD, of Rutgers University. Awarded in recognition of a...

Swartz Prize for Theoretical and Computational Neuroscience awarded to Kenneth Miller

(Society for Neuroscience) Kenneth Miller, Ph.D., will receive the 2018 Swartz Prize in Theoretical and Computational Neuroscience for his cumulative contributions to theoretical models or computation...

William Muñoz receives Nemko Prize in Cellular or Molecular Neuroscience

(Society for Neuroscience) The Society for Neuroscience (SfN) will award the Nemko Prize in Cellular or Molecular Neuroscience to William Muñoz, PhD, a student in the MD-PhD program at the New York U...

PubMed Articles [326 Associated PubMed Articles listed on BioPortfolio]

Reflections Over 50 Years of Pediatric Neuroscience Nursing.

Throughout the past 50 years, the role of the neuroscience nurse has become more specialized as we continue to keep pace with new innovations and improvement in care for our patients. This is evident ...

Visions for the Future of Neuroscience.

Neuroscience is a broad discipline that embraces technology at multiple scales to understand the brain and to develop potential therapies. Scientists share their perspectives on the evolution of neuro...

Corrigendum to "Prevention of the Severity of Post-ischemic Inflammation and Brain Damage by Simultaneous Knockdown of Toll-like Receptors 2 and 4" Neuroscience 373 (2018) 82-91.

Corrigendum to "Neuroprotective Effect of Sirt2-specific Inhibitor AK-7 Against Acute Cerebral Ischemia is P38 Activation-dependent in Mice" Neuroscience 374 (2018) 61-69.

Editorial: PET Imaging in Neuroscience.

Clinical Trials [99 Associated Clinical Trials listed on BioPortfolio]

Precision Psychiatry Continuity Clinic Project

This is a demonstration project focused on translating neuroscience insights into clinical practice. The researchers will evaluate how neuroscience assessments may be applied in the clinic...

Exercise and Pain Neuroscience Education for Patients With Neck Pain: Impact on Pain and Disability

This study will compare the effectiveness of pain neuroscience education and neck/shoulder traditional exercises versus pain neuroscience education and neck/shoulder suspension training ex...

Pain Neuroscience Education in Healthy Children

The primary objective of this study is to examine whether Pain Neuroscience Education for children is able to increase a child's knowledge on the neurophysiology of pain. In addition, thi...

Pain Neuroscience Education and Exercise

This study examined the effects of pain neuroscience education plus exercise when compared with exercise only in university students with chronic idiopathic neck pain.

Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial

The primary objective of this study is to provide duloxetine to investigators for the treatment of patients who have previously participated in neuroscience duloxetine clinical trials and ...

Companies [153 Associated Companies listed on BioPortfolio]

Proximagen Neuroscience plc

Proximagen Neuroscience plc is a publicly traded neuroscience research company focused on drug development for neurodegenerative disorders, including Parkinson's disease and Alzheimer's disease. Prox...

Neurosciences Victoria Limited

Our MissionNSV is dedicated to the continued development of the world-class neuroscience biocluster in Melbourne, Australia through a program of strategic investment in the gap between academic discov...

Society for Neuroscience

The Society for Neuroscience is a nonprofit membership organization of basic scientists and physicians who study the brain and nervous system. Recognizing the field's tremendous potential, the Society...

Cambridge NeuroScience Incorporated

Cambridge NeuroScience Incorporated is a biopharmaceutical company engaged in the discovery and development of proprietary pharmaceuticals to prevent or treat severe disorders of, or injuries to, the ...

Neurosciences Victoria Ltd

NSV® was formed in 2001 to facilitate technology transfer and inward investment into the vibrant and expanding Melbourne neuroscience cluster.NSV provides a "one-stop-shop" for current and potential ...

More Information about "Proximagen Neuroscience plc" on BioPortfolio

We have published hundreds of Proximagen Neuroscience plc news stories on BioPortfolio along with dozens of Proximagen Neuroscience plc Clinical Trials and PubMed Articles about Proximagen Neuroscience plc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Proximagen Neuroscience plc Companies in our database. You can also find out about relevant Proximagen Neuroscience plc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...


Corporate Database Quicklinks



Searches Linking to this Company Record